科伦博泰生物-B于2025年欧洲肿瘤内科学会大会上公布的多项创新药物研究成果
SKB BIOSKB BIO(HK:06990) Zhi Tong Cai Jing·2025-10-20 00:27

Core Viewpoint - The company announced the presentation of multiple clinical research results at the 2025 European Society for Medical Oncology (ESMO) conference held in Berlin from October 17 to 21, focusing on various antibody-drug conjugates (ADCs) targeting specific cancer markers [1] Group 1: Clinical Research Results - The company presented data on the TROP2-targeted ADC sac-TMT (佳泰莱) [1] - The company showcased results for the HER2-targeted ADC A166 (舒泰莱) [1] - The company also reported findings related to the Claudin18.2-targeted ADC SKB315 [1]